Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ROSE12 |
Trade Name | |
Synonyms | ROSE-12|ROSE 12 |
Drug Descriptions |
ROSE12 is an antibody that targets CTLA4, which potentially depletes regulatory T cells, enhances antibody-dependent cell cytotoxicity, and induces antitumor activity (Journal for ImmunoTherapy of Cancer 2024;12). |
DrugClasses | CTLA4 Antibody 32 |
CAS Registry Number | NA |
NCIT ID | C203418 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Atezolizumab + ROSE12 | Atezolizumab ROSE12 | 0 | 1 |
ROSE12 | ROSE12 | 0 | 1 |